8,049
Views
37
CrossRef citations to date
0
Altmetric
Review

Parasitic diseases of the central nervous system: lessons for clinicians and policy makers

, , , &
Pages 401-414 | Received 31 Dec 2015, Accepted 15 Feb 2016, Published online: 04 Mar 2016

References

  • Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis. 2006;42:115–125.
  • Graeff-Teixeira C, Da Silva AC, Yoshimura K. Update on eosinophilic meningoencephalitis and its clinical relevance. Clin Microbiol Rev. 2009;22:322–348.
  • Nash TE. Parasitic diseases that cause seizures. Epilepsy Curr. 2014;14:29–34.
  • Abdel Razek AA, Watcharakorn A, Castillo M. Parasitic diseases of the central nervous system. Neuroimaging Clin N Am. 2011;21:815–841.
  • Vezzani A, Fujinami RS, White HS, et al.. Infections, inflammation and epilepsy. Acta Neuropathol. 2016; 131:211–234.
  • Serem GK, Newton CR, Kariuki SM. Incidence, causes and phenotypes of acute seizures in Kenyan children post the malaria-decline period. BMC Neurol. 2015;15:180.
  • Ngugi AK, Bottomley C, Kleinschmidt I, et al.. Prevalence of active convulsive epilepsy in Sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol. 2013;12:253–263.
  • Kamuyu G, Bottomley C, Mageto J, et al. Exposure to multiple parasites is associated with the prevalence of active convulsive epilepsy in sub-Saharan Africa. PLoS Negl Trop Dis. 2014;8:e2908.
  • Showler AJ, Wilson ME, Kain KC, et al.. Parasitic diseases in travelers: a focus on therapy. Expert Rev Anti Infect Ther. 2014;12:497–521.
  • Carabin H, Ndimubanzi PC, Budke CM, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011;5:e1152.
  • Carpio A, Fleury A, Hauser WA. Neurocysticercosis: five new things. Neurol Clin Pract. 2013;3:118–125.
  • Carpio A, Romo ML. The relationship between neurocysticercosis and epilepsy: an endless debate. Arq Neuropsiquiatr. 2014;72:383–390.
  • Cárdenas G, Jung H, Ríos C, et al.. Severe cysticercal meningitis: clinical and imaging characteristics. Am J Trop Med Hyg. 2010;82:121–125.
  • Fleury A, Garcia E, Hernandez M, et al. Neurocysticercosis: HP10 antigen detection is useful for the follow-up of the severe patients. PLoS Negl Trop Dis. 2013;7:e2096.
  • Ngoungou EB, Bhalla D, Nzoghe A, et al. Toxoplasmosis and epilepsy–systematic review and meta analysis. PLoS Negl Trop Dis. 2015;9:e0003525.
  • Groer MW, Yolken RH, Xiao JC, et al. Prenatal depression and anxiety in Toxoplasma gondii-positive women. Am J Obsetet Gynecol. 2011;204:433.
  • Brooks JM, Carrillo GL, Su J, et al. Toxoplasma gondii infections alter gabaergic synapses and signaling in the central nervous system. Mbio. 2015;6:e01428-15.
  • Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1–16.
  • World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases; a roadmap for implementation (executive summary). [2012; cited 2015 Dec 29]. Available from: http://apps.who.int/iris/bitstream/10665/70809/1/WHO_HTM_NTD_2012.1_eng.pdf.
  • Böttcher D, Bangoura B, Schmäschke R, et al. Diagnostics and epidemiology of alveolar echinococcosis in slaughtered pigs from large-scale husbandries in Germany. Parasitol Res. 2013;112:629–636.
  • Davidson RK, Romig T, Jenkins E, et al. The impact of globalisation on the distribution of Echinococcus multilocularis. Trends Parasitol. 2012;28:239–247.
  • Newton CR, Preux P-M, Singhi P. Parasitic disorders. Handb Clin Neurol. 2013;112:1139–1152.
  • Ferrari TC, Moreira PR. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol. 2011;10:853–864.
  • Carod-Artal FJ. Neuroschistosomiasis. Expert Rev Anti Infect Ther. 2010;8:1307–1318.
  • Katchanov J, Nawa Y. Helminthic invasion of the central nervous system: many roads lead to Rome. Parasitol Int. 2010;59:491–496.
  • Pittella JE. Pathology of CNS parasitic infections. Handb Clin Neurol. 2013;114:65–88.
  • White NJ, Pukrittayakamee S, Hien TT, et al. Malaria. Lancet. 2014;383:723–735.
  • Quattrocchi G, Nicoletti A, Marin B, et al. Toxocariasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6:e1775.
  • Kaiser C, Pion SD, Boussinesq M. Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7:e2147.
  • Colebunders R, Post R, O’Neill S, et al. Nodding syndrome since 2012: recent progress, challenges and recommendations for future research. Trop Med Int Health. 2015;20:194–200.
  • Winkler AS, Friedrich K, Velicheti S, et al. MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study. Afr Health Sci. 2013;13:529–540.
  • Perez CJ, Lymbery AJ, Thompson RC. Reactivation of Chagas disease: implications for global health. Trends Parasitol. 2015;31:595–603.
  • Leon-Sarmiento FE, Mendoza E, Torres-Hillera M, et al. Trypanosoma cruzi-associated cerebrovascular disease: a case-control study in Eastern Colombia. J Neurol Sci. 2004;217:61–64.
  • Wilkins PP. Immunodiagnosis of CNS parasitic infections. Handb Clin Neurol. 2013;114:23–36.
  • Deckers N, Dorny P. Immunodiagnosis of Taenia solium taeniosis/cysticercosis. Trends Parasitol. 2010;26:137–144.
  • Ferrer E, Bonay P, Foster-Cuevas M, et al. Molecular cloning and characterisation of Ts8B1, Ts8B2 and Ts8B3, three new members of the Taenia solium metacestode 8 kDa diagnostic antigen family. Mol Biochem Parasitol. 2007;152:90–100.
  • Harrison LJ, Joshua GW, Wright SH, et al.. Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis. Parasite Immunol. 1989;11:351–370.
  • Brandt JR, Geerts S, De Deken R, et al. A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis. Int J Parasitol. 1992;22:471–477.
  • Garcia HH, Parkhouse RM, Gilman RH, et al. Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans Royal Soc Trop Med Hyg. 2000;94:673–676.
  • Nguekam JP, Zoli AP, Ongolo-Zogo P, et al. Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA. Parasite. 2003;10:65–68.
  • Rodriguez S, Dorny P, Tsang VC, et al. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis. 2009;199:1345–1352.
  • Hernández M, Gonzalez LM, Fleury A, et al. Neurocysticercosis: detection of Taenia solium DNA in human cerebrospinal fluid using a semi-nested PCR based on HDP2. Ann Trop Med Parasitol. 2008;102:317–323.
  • Blanchard N, Dunay IR, Schlüter D. Persistence of Toxoplasma gondii in the central nervous system: a fine-tuned balance between the parasite, the brain and the immune system. Parasite Immunol. 2015;37:150–158.
  • Slemenda SB, Maddison SE, Jong EC, et al.. Diagnosis of paragonimiasis by immunoblot. Am J Trop Med Hyg. 1988;39:469–471.
  • Mishra SK, Newton CR. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol. 2009;5:189–198.
  • Vidal JE, Sztajnbok J, Seguro AC. Eosinophilic meningoencephalitis due to Toxocara canis: case report and review of the literature. Am J Trop Med Hyg. 2003;69:341–343.
  • Umezawa ES, Nascimento MS, Kesper N Jr., et al. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas’ disease. J Clin Microbiol. 1996;34:2143–2147.
  • Saini J, Gupta RK, Jain KK. Intracranial infections: key neuroimaging findings. Semin Roentgenol. 2014;49:86–98.
  • Mullins ME. Emergent neuroimaging of intracranial infection/inflammation. Radiol Clin North Am. 2011;49:47–62.
  • Shih RY, Koeller KK. Bacterial, fungal, and parasitic infections of the central nervous system: radiologic-pathologic correlation and historical perspectives. Radiographics. 2015;35:1141–1169.
  • Kumar GG, Mahadevan A, Guruprasad AS, et al. Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature. J Magn Reson Imaging. 2010;31:1469–1472.
  • Barcelo C, Catalaa I, Loubes-Lacroix F, et al. Interest of MR perfusion and MR spectroscopy for the diagnostic of atypical cerebral toxoplasmosis. J Neuroradiol. 2010;37:68–71.
  • Jayakumar PN, Chandrashekar HS, Ellika S. Imaging of parasitic infections of the central nervous system. Handb Clin Neurol. 2013;114:37–64.
  • Liu H, Lim CC, Feng X, et al. MRI in cerebral schistosomiasis: characteristic nodular enhancement in 33 patients. AJR Am J Roentgenol. 2008;191:582–588.
  • Drugs for Parasitic Infections. Treatment guidelines from the medical letter. Vol. 8 (Suppl). New Rochelle (NY): The Medical Letter, Inc.; 2010.
  • Garcia HH, Gonzales I, Lescano AG, et al.. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014;14:687–695.
  • Kaur S, Singhi P, Singhi S, et al.. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis. 2009;28:403–406.
  • Morillo CA, Marin-Neto JA, Avezum A, et al.. Randomized trial of benznidazole for chronic chagas’ cardiomyopathy. N Engl J Med. 2015;373:1295–1306.
  • Alirol E, Schrumpf D, Amici Heradi J, et al.. Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médicins Sans Frontièrs experience in the Democratic Republic of the Congo. Clin Infect Dis. 2013;56:195–203.
  • Kuepfer I, Schmid C, Allan M, et al. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness. PLoS Negl Trop Dis. 2012;6:e1695.
  • Debrah AY, Specht S, Klarmann-Schulz U, et al.. Doxycycline leads to sterility and enhanced killing of female onchocerca volvulus worms in an area with persistent microfilaridermia after repeated ivermectin treatment: a randomized, placebo-controlled, double-blind trial. Clin Infect Dis. 2015;61:517–526.
  • Mohanty S, Mishra SK, Patnaik R, et al.. Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial. Clin Infect Dis. 2011;53:349–355.
  • Maude RJ, Hoque G, Hasan MU, et al. Timing of enteral feeding in cerebral malaria in resource-poor settings: a randomized trial. PLoS One. 2011;6:e27273.
  • World Health Organization. Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases. [2010; cited 2015 Dec 29]. Available from: http://apps.who.int/iris/bitstream/10665/44440/1/9789241564090_eng.pdf.
  • World Health Organization. Echinococcosis, fact sheet no.377. [2015; cited 2015 Dec 29]. Available from: http://www.who.int/mediacentre/factsheets/fs377/en/.
  • World Health Organization. Malaria, fact sheet no.094. [2015; cited 2015 Dec 29]. Available from: http://www.who.int/mediacentre/factsheets/fs094/en/.
  • World Health Organization. WHO estimates of the global burden of foodborne diseases. [2015; cited 2015 Dec 29]. Available from: http://apps.who.int/iris/bitstream/10665/199350/1/9789241565165_eng.pdf?ua=1.
  • Hotez PJ, Alvarado M, Basanez MG, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014;8:e2865.
  • Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–2223.
  • World Health Organization. Investing to overcome the global impact of neglected tropical diseases; third WHO report on neglected tropical diseases. [2015; cited 2015 Dec 29]. Available from: http://apps.who.int/iris/bitstream/10665/152781/1/9789241564861_eng.pdf?ua=1.
  • Ndimubanzi PC, Carabin H, Budke CM, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010;4:e870.
  • Torgerson PR, Macpherson CN. The socioeconomic burden of parasitic zoonoses: global trends. Vet Parasitol. 2011;182:79–95.
  • World Health Organization. Assembling a framework for intensified control of taeniasis and neurocysicercosis caused by taenia solium. [2013; cited 2015 Dec 29]. Available from: http://apps.who.int/iris/bitstream/10665/153237/1/9789241508452_eng.pdf?ua=1.
  • Conteh L, Engels T, Molyneux DH. Socioeconomic aspects of neglected tropical diseases. Lancet. 2010;375:239–247.
  • World Health Organization. World malaria report. [2014; cited 2015 Dec 29]. Available from: http://www.who.int/malaria/publications/world_malaria_report_2014/report/en/.
  • World Health Organization. Onchocerciasis, fact sheet no.374. [2015; cited 2015 Dec 29]. Available from: http://www.who.int/mediacentre/factsheets/fs374/en/.
  • World Health Assembly (WHA). Resolutions on neglected tropical diseases: 1948–2013. [cited 2015 Dec 29]. Available from: http://www.who.int/neglected_diseases/mediacentre/resolutions/en/).
  • Sixty-eighth World Health Assembly adopts resolution on epilepsy. [cited 2015 Dec 29]. Available from: http://www.who.int/mental_health/neurology/epilepsy/resolution_68_20/en/.
  • The World Bank. People, pathogens, and our planet. Volume 2: the economics of one health. Report no. 69145-GLB. [2012; cited 2015 Dec 29]. Available from: https://openknowledge.worldbank.org/bitstream/handle/10986/11892/691450ESW0whit0D0ESW120PPPvol120web.pdf?sequence=1.